Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 85/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
3(75.0%)
Early Phase 1
1(25.0%)
4Total
N/A(3)
Early Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06689839Not ApplicableRecruiting

Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Role: lead

NCT05866640Early Phase 1Recruiting

Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Role: lead

NCT06069661Not ApplicableWithdrawn

U.S. Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Role: lead

NCT05893082Not ApplicableCompleted

Multicenter Feasibility Trial of the F2 Filter and Delivery System for Embolic Protection During TAVR

Role: lead

All 4 trials loaded